This is not fiction; it’s an international investigation published on April 12th by the ICIJ, the consortium that uncovered the Panama Papers, with 124 journalists in 36 countries.
Francisco Chávez, a show producer from Mérida, Yucatán, diagnosed with kidney cancer, received Keytruda at the ISSSTE Elvia Carrillo Puerto public hospital. By his fourth dose, he began to suffer tremors, paralysis, and a severe spike in his blood sugar.
Chávez photographed every box of Keytruda he was given and filed a complaint. He sent the photos to Merck, the original manufacturer.
The laboratory sent personnel to the hospital, collected three samples from two different batches, and analyzed them at its forensic laboratory in Pennsylvania.
The result: “Irregularities were identified that do not correspond to the characteristics of the products manufactured or distributed by our company.” In other words: it was counterfeit.
COFEPRIS confirmed that at least two batches of Keytruda are circulating in Mexico with characteristics that do not match the original product. It warned that they represent “a serious health risk” because their origin, manufacturing process, and raw materials are unknown.
Chávez saw the health alert on television with the batch numbers. He checked his photos: it was the same batch that had been injected into him. A man fighting cancer, trusting his public hospital, and they injected him with something, no one knows what it was.
The Attorney General’s Office is investigating. But someone bought, distributed, and injected counterfeit medicine into cancer patients. That’s not negligence. It’s corruption that kills.
Source: MGM Noticias
